A study on Tibetans living at high altitudes identified novel risk genes for schizophrenia (SCZ) related to hypoxia, suggesting a unique genetic signature for SCZ in this population. Highlights: Whole-exome sequencing of 47 SCZ cases and 53 controls in Tibetans revealed 275 potential novel risk variants and two known variants. One gene, C5orf42, surpassed exome-wide …
PCSK9 inhibitors significantly reduce the risk of amyotrophic lateral sclerosis (ALS) but increase the risk of Parkinson’s disease (PD). Highlights: ALS Risk Reduction: PCSK9 inhibitors marginally reduced the risk of ALS with an odds ratio of 0.89 (p = 0.048). PD Risk Increase: PCSK9 inhibitors increased the risk of Parkinson’s disease, with an odds ratio …
Lecanemab shows promise in treating Alzheimer’s disease by reducing clinical deterioration and amyloid-beta plaques, but it has significant adverse effects and requires further research for confirmation. Highlights: FDA Approval: The US FDA authorized lecanemab for Alzheimer’s disease treatment in January 2023. Efficacy: Lecanemab significantly reduces clinical deterioration and amyloid-beta plaques in the brain. Adverse Effects: …
A study identified a panel of eight plasma biomarkers that can predict Parkinson’s disease up to seven years before motor symptoms appear. Highlights: Biomarker Panel: The study validated a panel of 8 proteins, including Granulin precursor and Complement C3, using mass spectrometry, which can differentiate Parkinson’s patients from healthy controls and identify pre-motor individuals with …
TLDR: Herpes zoster vaccination is linked to a lower risk of dementia, but more studies are needed to confirm this association. Highlights: Five high-quality studies involving 103,615 vaccinated patients were analyzed. Herpes zoster vaccination was associated with a reduced risk of dementia (pooled odds ratio: 0.84). High variability among studies was observed, necessitating a random …
TLDR: A study identified specific gut microbial features in Parkinson’s disease (PD) across different countries, highlighting increased α-diversity, altered bacterial species, and decreased metabolites in PD patients. Highlights: Increased α-Diversity: The study found higher α-diversity in PD patients across six datasets from different countries. Altered Bacterial Species: Species such as Akkermansia muciniphila were increased, while …
TLDR: GLP-1 agonists were found to significantly reduce the risk of dementia in older individuals with type 2 diabetes mellitus (T2DM) compared to DPP-4 inhibitors and sulfonylureas. Highlights: A sequential trial emulation was conducted using data from Swedish national registers from 2010 to 2020, involving 88,381 participants aged 65 or older with T2DM. The incidence …
TLDR: Researchers demonstrated that intranasal administration of the peptide FITC-PHDP5-CPP reverses early cognitive impairment in Alzheimer’s disease (AD) model mice, showing potential as a treatment for AD-associated cognitive decline. Highlights: PHDP5, derived from the pleckstrin homology domain of dynamin 1, inhibits the interaction between dynamin and microtubules, rescuing synaptic dysfunction caused by tau accumulation. The …
TLDR: This study provides evidence that high salt intake is causally associated with an increased risk of developing dementia, including Alzheimer’s disease (AD) and undefined dementia. Highlights: Causal Association: High salt intake is significantly associated with an increased risk of any dementia (OR = 1.73) and specifically Alzheimer’s disease (OR = 2.10). Cognitive Performance: Higher …
New research reveals that people with a history of methamphetamine dependence face a startling elevated risk of developing Parkinson’s disease or related movement disorders later in life. Key Facts: Individuals dependent on methamphetamine had almost 3 times the rate of Parkinson’s outcomes compared to matched controls from the general population. For women with methamphetamine dependence, the risk …
